Fig. 1

The trial coordination board (TCB) promotes cooperation between the platform trials (both EU-funded or not EU-funded) and establishes a dialogue with policymakers, while the Joint Access Advisory Mechanism (JAAM) acts as an access board conducting independent assessment of the public health value of individual intervention arms and making recommendations on the most suitable EU-funded platform trial to test a drug candidate